Inhibition of tumor growth and tumor metastasis by a Chinese herbal formula - ZYD88, in an animal model with metastatic Lewis lung carcinoma

Oncology Reports

Volumn 17, Issue 6, 2007, Pages 1391-1397

  Duan, Yan Wen ^a,b   Huang, Ying ^a   Cai, Li Qun ^b   Duan, Quwen ^a   Zhu, Yuan Shan ^a,b  

^a Changsha Cihang Research Institute of Materia Medica   (China)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Angiogenesis; Herb; Lung cancer; Metastasis

Indexed keywords

HERBACEOUS AGENT; UNCLASSIFIED DRUG; ZYD88 CPD;

ANIMAL; ARTICLE; C57BL MOUSE; CAPILLARY; CELL PROLIFERATION; DISEASE MODEL; DRUG EFFECT; DRUG SCREENING; IMMUNITY; LEWIS CARCINOMA; LIVER TUMOR; METASTASIS; MOUSE; NEOVASCULARIZATION (PATHOLOGY); VASCULARIZATION;

ANIMALS; CAPILLARIES; CARCINOMA, LEWIS LUNG; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; IMMUNITY; LIVER NEOPLASMS; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 34548013986     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.6.1391     Document Type: Article

References (24)

1. Chambers AF, Groom AC and MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2: 563-572, 2002. (Pubitemid 37328923)
2. Fidler IJ: The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458, 2003.
3. Liotta LA and Kohn E: Cancer invasion and metastases. JAMA 263: 1123-1126, 1990. (Pubitemid 20047447)
4. Weiss L: Metastasis of cancer: a conceptual history from antiquity to the 1990s. Cancer Metastasis Rev 19: I-383, 2000.
5. Yu R: Taking the path of combining traditional Chinese medicine with western medicine in cancer research and control. Chin Med J 108: 732-733, 1995.
6. Zheng S, Yang H, Zhang S, et al: Initial study on naturally occurring products from traditional Chinese herbs and vegetables for chemoprevention. J Cell Biochem S27: 106-112, 1997. (Pubitemid 28222126)
7. Niu H and Liu J: Advances in TCM treatment for metastasis of tumors. J Tradit Chin Med 23: 151-157, 2003. (Pubitemid 41238456)
8. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
9. Duan Y, Huang Y, Duan Q and Zhu YS: Characterization of ZYD88, a Chinese herbal medicine, and its effects on tumor cell growth and colony formation in SPC-A1 lung and Lovo colon adenocarcinoma cells. Chin J Cancer Res (in press).
10. Kimura Y and Okuda H: Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr 131: 1844-1849, 2001. (Pubitemid 32520456)
11. Huang Y, Duan Q, Zhu YS and Duan Y: In vivo antitumor activity of ZYD88, a Chinese herbal medicine in animal models with S180 sarcoma and Ehrlich tumor. J Soc Integrative Oncol (In press).
12. Guo F: Enhancement of the therapeutic effect and red cell immune function by radix Trichosanthis in mice bearing Ehrlich ascites carcinoma. Zhong Xi Yi Jie He Za Zhi 9: 418-420, 1989.
13. Poggi A, Polentarutti N, Benedetta DM, de Gaetano G and Garattini S: Blood coagulation changes in mice bearing Lewis lung carcinoma, a metastasizing tumor. Cancer Res 37: 272-277, 1977. (Pubitemid 8008647)
14. Zhu YS, Huang Y, Cai LQ, et al: A Chinese medicinal herbal formula ZYD88 inhibits cell growth and promotes cell apoptosis in prostatic tumor cells. Oncol Rep 10: 1633-1639, 2003.
15. Folkman J: Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29: 15-18, 2002.
16. O'Reilly MS, Holmgren L, Chen C and Folkman J: Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 2: 689-692, 1996. (Pubitemid 26191958)
17. Kuba K, Matsumoto K, Date K, Shimura H, Tanaka M and Nakamura T: HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res 60: 6737-6743, 2000.
18. Schirrmacher V, Umansky V and Rocha M: Immunotherapy of metastases. Curr Top Microbiol Immunol 213: 189-216, 1996. (Pubitemid 26165102)
19. O'Byrne KJ, Dalgleish AG, Browning MJ, Steward WP and Harris AL: The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. Eur J Cancer 36: 151-169, 2000. (Pubitemid 30102191)
20. Siegel I and Gleicher N: Red cell immune adherence (RCIA): its application in cancer and autoimmune disease. Immunol Commun 10: 433-449, 1981. (Pubitemid 12205646)
21. Currie MS, Vala M, Pisetsky DS, Greenberg CS, Crawford J and Cohen HJ: Correlation between erythrocyte CR1 reduction and other blood proteinase markers in patients with malignant and inflammatory disorders. Blood 75: 1699-1704, 1990. (Pubitemid 20145759)
22. Hadden JW: Immunodeficiency and cancer: prospects for correction. Int Immunopharmacol 3: 1061-1071, 2003.
23. Shi YQ, Fukai T, Sakagami H, et al: Cytotoxic and DNA damage-inducing activities of low molecular weight phenols from rhubarb. Anticancer Res 21: 2847-2853, 2001. (Pubitemid 33054466)
24. Wietrzyk J, Opolski A, Madej J and Radzikowski C: Anti-tumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation. In Vivo 14: 357-362, 2000. (Pubitemid 30315861) Ministry of Science and Technology Foreign Experts Affairs